{"title":"曼陀罗叶80%甲醇提取物对链脲佐菌素诱导的糖尿病小鼠的抗糖尿病作用。","authors":"Temesgen Baylie, Assefa Kebad, Tiget Ayelgn, Markeshaw Tiruneh, Kibur Hunie Tesfa","doi":"10.2147/JEP.S426925","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Managing diabetes mellitus with currently available drugs is costly, and the chances of side effects are high, leading to further studies for new and better medications from plant sources with the affordable and lower side effects. This study aimed to evaluate the anti-diabetic effects of <i>Datura stramonium</i> Linn (Solanaceae) Leaves Extract in Streptozotocin- Induced Diabetic Mice.</p><p><strong>Methods: </strong>Male Swiss albino mice were induced into diabetes using 150mg/kg of STZ. Mice were allocated randomly into six groups, five mice per group. Group I was a normal control, Group II was Diabetic negative control, group III was Diabetic positive control, Group IV-VI were Diabetic Mice that treated with extract (100, 200 and 400 mg/kg) for 14 days. The FBG measurements were done on 0, 7th, and 14th days of treatment. After 14th day of treatment the mice were anesthetized with diethyl ether. Then, blood was drawn by cardiac puncture to assess TC, TG, LDL-C, and HDL-C. The antioxidant activity of the extract was determined using a DPPH assay. The data were entered into Epi-Data version 4.6, exported to SPSS version 26.0, and analyzed using a one-way ANOVA followed by a Tukey post hoc test. P < 0.05 was considered statistically significant.</p><p><strong>Results: </strong>The extract of <i>D. stramonium</i> reduced the FBG level by 19.71%, 30.27%, 40.95%, and 45.67%, respectively, for <i>D. stramonium</i> 100, 200, 400, and GLC 5 mg/kg on the 14th day of treatment. Diabetic mice treated with <i>D. stramonium</i> for 14 days showed a significant decrease in serum TC, LDL, and serum TG and a significant increase in body weight, and HDL level as compared to diabetic negative control. Antioxidant activities of the leaves extract were comparable to ascorbic acid with an IC50 of 172.79 μg/mL.</p><p><strong>Conclusion: </strong>These findings revealed that the <i>D. stramonium</i> leaves extract possesses significant Anti-diabetic activities.</p>","PeriodicalId":15846,"journal":{"name":"Journal of Experimental Pharmacology","volume":"15 ","pages":"375-389"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a7/3e/jep-15-375.PMC10590592.pdf","citationCount":"0","resultStr":"{\"title\":\"Anti-Diabetic Effects of the 80% Methanolic Extract of Datura Stramonium Linn (Solanaceae) Leaves in Streptozotocin- Induced Diabetic Mice.\",\"authors\":\"Temesgen Baylie, Assefa Kebad, Tiget Ayelgn, Markeshaw Tiruneh, Kibur Hunie Tesfa\",\"doi\":\"10.2147/JEP.S426925\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Managing diabetes mellitus with currently available drugs is costly, and the chances of side effects are high, leading to further studies for new and better medications from plant sources with the affordable and lower side effects. This study aimed to evaluate the anti-diabetic effects of <i>Datura stramonium</i> Linn (Solanaceae) Leaves Extract in Streptozotocin- Induced Diabetic Mice.</p><p><strong>Methods: </strong>Male Swiss albino mice were induced into diabetes using 150mg/kg of STZ. Mice were allocated randomly into six groups, five mice per group. Group I was a normal control, Group II was Diabetic negative control, group III was Diabetic positive control, Group IV-VI were Diabetic Mice that treated with extract (100, 200 and 400 mg/kg) for 14 days. The FBG measurements were done on 0, 7th, and 14th days of treatment. After 14th day of treatment the mice were anesthetized with diethyl ether. Then, blood was drawn by cardiac puncture to assess TC, TG, LDL-C, and HDL-C. The antioxidant activity of the extract was determined using a DPPH assay. The data were entered into Epi-Data version 4.6, exported to SPSS version 26.0, and analyzed using a one-way ANOVA followed by a Tukey post hoc test. P < 0.05 was considered statistically significant.</p><p><strong>Results: </strong>The extract of <i>D. stramonium</i> reduced the FBG level by 19.71%, 30.27%, 40.95%, and 45.67%, respectively, for <i>D. stramonium</i> 100, 200, 400, and GLC 5 mg/kg on the 14th day of treatment. Diabetic mice treated with <i>D. stramonium</i> for 14 days showed a significant decrease in serum TC, LDL, and serum TG and a significant increase in body weight, and HDL level as compared to diabetic negative control. Antioxidant activities of the leaves extract were comparable to ascorbic acid with an IC50 of 172.79 μg/mL.</p><p><strong>Conclusion: </strong>These findings revealed that the <i>D. stramonium</i> leaves extract possesses significant Anti-diabetic activities.</p>\",\"PeriodicalId\":15846,\"journal\":{\"name\":\"Journal of Experimental Pharmacology\",\"volume\":\"15 \",\"pages\":\"375-389\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a7/3e/jep-15-375.PMC10590592.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Experimental Pharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/JEP.S426925\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Experimental Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/JEP.S426925","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
背景:用目前可用的药物治疗糖尿病成本高昂,副作用发生的几率很高,因此需要进一步研究从植物来源获得的新的更好的药物,这些药物具有负担得起和更低的副作用。本研究旨在评价曼陀罗叶提取物对链脲佐菌素诱导的糖尿病小鼠的抗糖尿病作用。将小鼠随机分为六组,每组五只。第一组为正常对照,第二组为糖尿病阴性对照,第三组为糖尿病阳性对照,第IV-VI组为用提取物(100、200和400 mg/kg)治疗14天的糖尿病小鼠。FBG测量在治疗的第0天、第7天和第14天进行。治疗14天后,用乙醚麻醉小鼠。然后,通过心脏穿刺抽血以评估TC、TG、LDL-C和HDL-C。使用DPPH测定法测定提取物的抗氧化活性。将数据输入Epi data 4.6版,导出到SPSS 26.0版,并使用单因素方差分析和Tukey事后检验进行分析。P<0.05被认为具有统计学意义。结果:在治疗第14天,对于100、200、400和GLC 5mg/kg的草,草提取物分别降低了19.71%、30.27%、40.95%和45.67%的FBG水平。stramonium治疗糖尿病小鼠14天 与糖尿病阴性对照组相比,血清TC、LDL和血清TG显著降低,体重和HDL水平显著增加。其抗氧化活性与抗坏血酸相当,IC50为172.79μg/mL。
Anti-Diabetic Effects of the 80% Methanolic Extract of Datura Stramonium Linn (Solanaceae) Leaves in Streptozotocin- Induced Diabetic Mice.
Background: Managing diabetes mellitus with currently available drugs is costly, and the chances of side effects are high, leading to further studies for new and better medications from plant sources with the affordable and lower side effects. This study aimed to evaluate the anti-diabetic effects of Datura stramonium Linn (Solanaceae) Leaves Extract in Streptozotocin- Induced Diabetic Mice.
Methods: Male Swiss albino mice were induced into diabetes using 150mg/kg of STZ. Mice were allocated randomly into six groups, five mice per group. Group I was a normal control, Group II was Diabetic negative control, group III was Diabetic positive control, Group IV-VI were Diabetic Mice that treated with extract (100, 200 and 400 mg/kg) for 14 days. The FBG measurements were done on 0, 7th, and 14th days of treatment. After 14th day of treatment the mice were anesthetized with diethyl ether. Then, blood was drawn by cardiac puncture to assess TC, TG, LDL-C, and HDL-C. The antioxidant activity of the extract was determined using a DPPH assay. The data were entered into Epi-Data version 4.6, exported to SPSS version 26.0, and analyzed using a one-way ANOVA followed by a Tukey post hoc test. P < 0.05 was considered statistically significant.
Results: The extract of D. stramonium reduced the FBG level by 19.71%, 30.27%, 40.95%, and 45.67%, respectively, for D. stramonium 100, 200, 400, and GLC 5 mg/kg on the 14th day of treatment. Diabetic mice treated with D. stramonium for 14 days showed a significant decrease in serum TC, LDL, and serum TG and a significant increase in body weight, and HDL level as compared to diabetic negative control. Antioxidant activities of the leaves extract were comparable to ascorbic acid with an IC50 of 172.79 μg/mL.
Conclusion: These findings revealed that the D. stramonium leaves extract possesses significant Anti-diabetic activities.